Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DAVITA INC.DVA · Entity 3482 | Director | August 15, 2026 | August 18, 2026 |
| Fortive CorpFTV · Entity 3303 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DAVITA INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,091 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 278 · Balance 8,091 |
Fortive Corp
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,470 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,350 · Balance 5,470 F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (05/07/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 1,520 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (02/26/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 1,870 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/11/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-13 · Disposition to issuer · Disposed 1,798 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-12-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2026 Filed Aug 18, 2026 22:10 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000121 · wk-form4_1787091030.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,091 Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:50 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001775520-26-000003 · wk-form4_1781211027.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,470 F1 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:11 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000084 · wk-form4_1779135108.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,813 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000036 · wk-form4_1773778147.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 Read SEC document |
| November 15, 2025 Filed Nov 17, 2025 23:46 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000177 · wk-form4_1763423179.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,231 Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:20 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000147 · wk-form4_1755638446.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,820 Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:02 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,140 | $0.00 Strike: $70.26 | $0.00 |
DisclosureSEC source: 0001659166-25-000089 · wk-form4_1749081732.xml · derivative · entry 2 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Underlying: Common Stock · 2,140 shares Expires 2035-06-02 Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:02 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-25-000089 · wk-form4_1749081732.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,120 F1 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| May 15, 2025 Filed May 17, 2025 01:15 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 348 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000105 · wk-form4_1747444508.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,451 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:42 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 349 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000066 · wk-form4_1742341335.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,103 Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:25 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000199 · wk-form4_1732051539.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,754 Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 22:23 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000143 · wk-form4_1724106208.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,442 Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:31 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000111 · wk-form4_1715981460.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,109 Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 00:28 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000059 · wk-form4_1710894481.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,746 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:44 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000223 · wk-form4_1700261070.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,380 Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 21:13 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000193 · wk-form4_1692306821.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,851 Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:40 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000141 · wk-form4_1684359594.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,376 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:41 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000057 · wf-form4_167908926974305.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:30 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 677 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000184 · wf-form4_166863780656395.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,202 Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 23:25 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 514 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000147 · wf-form4_166069228616295.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525 Read SEC document |
| May 15, 2022 Filed May 17, 2022 22:13 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000100 · wf-form4_165282560305638.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 01:31 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 429 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000029 · wf-form4_164748069302014.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536 Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (03/11/2021) · Derivative | 1,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013210 · marketforms-54642.xml · derivative · entry 4 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,798 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (02/26/2020) · Derivative | 1,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013210 · marketforms-54642.xml · derivative · entry 3 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,870 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (05/07/2019) · Derivative | 1,520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013210 · marketforms-54642.xml · derivative · entry 2 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,520 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 23:01 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000179 · wf-form4_163719009609741.xml · nonDerivative · entry 1 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107 Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 16:04 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-21-000032 · wf-form4_161558303895101.xml · derivative · entry 2 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 1,787 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 16:51 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,842 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000034 · wf-form4_158275385163479.xml · derivative · entry 2 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,842 Underlying: Common Stock · 1,842 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| May 07, 2019 Filed May 8, 2019 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000046 · wf-form4_155734578626961.xml · derivative · entry 2 Moore Gregory J. · CIK 0001775520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,489 Underlying: Common Stock · 1,489 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.